Darling Ingredients Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DAR research report →
Range $65 – $88
Price Chart
About the company
Darling Ingredients Inc. specializes in the development and production of natural ingredients sourced from various organic bio-nutrients, encompassing both edible and inedible materials. The company's operations are structured into three primary segments: Feed Ingredients, Food Ingredients, and Fuel Ingredients.
- CEO
- Randall C. Stuewe Randy
- IPO
- 1994
- Employees
- 15,000
- HQ
- Irving, TX, US
Get TickerSpark's AI analysis on DAR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $7.84B
- P/E
- 9.69
- Fwd P/E
- 7.49
- PEG
- 0.01
- P/S
- 1.18
- P/B
- 1.52
- EV/EBITDA
- 7.28
- Div Yield
- 0.00%
- Gross Margin
- 25.38%
- Op Margin
- 16.24%
- Net Margin
- 12.46%
- ROE
- 16.72%
- ROIC
- 9.07%
Latest fiscal year · YoY change
- Revenue
- $6.14B+7.4%
- Gross Profit
- $969.46M-24.1%
- Op Income
- $395.80M
- Net Income
- $62.80M-77.5%
- EPS
- $0.40-77.1%
- OCF Growth
- +26.3%
- FCF Growth
- +34.0%
- 52W High
- $69.98
- 52W Low
- $31.81
- 50D MA
- $58.69
- 200D MA
- $59.10
- Beta
- 0.97
- RSI (14)
- 36
- Avg Volume
- 2.45M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Darling Ingredients reported a strong third quarter with higher sales, much higher earnings, and $514 million of adjusted EBITDA, while emphasizing debt reduction, robust cash generation from DGD, and a reaffirmed full-year EBITDA outlook.· October 29, 2026
- Net income rose to $267 million, or $1.67 per diluted share, versus $19 million, or $0.12, a year ago; Q3 combined adjusted EBITDA was $514 million versus $245 million last year.
- DGD contributed $204 million of EBITDA on 315 million gallons sold at about $1.30 per gallon average margin, though management said hedge timing, a hydrogen outage, and lower RIN values pressured the quarter.
- The company reduced net debt by approximately $420 million in Q3 and ended with leverage around 1.7x; it also bought back about $76 million of stock.
- Management reaffirmed 2026 combined adjusted EBITDA guidance of $2.2 billion to $2.3 billion and said net debt should be at or below $3 billion by year-end.
- Core ingredients and protein demand were described as resilient, while tariffs continued to disrupt parts of Food and Feed in the near term.
Third-quarter 2026 net sales were $1.8 billion, up from $1.6 billion in the third quarter of 2025. Net income was $267 million, or $1.67 per GAAP diluted share, versus $19 million, or $0.12 per share, a year ago. Third-quarter combined adjusted EBITDA was $514 million versus $245 million last year; year-to-date combined adjusted EBITDA exceeded $1.6 billion versus $690 million a year ago. Darling’s share of DGD EBITDA was $204 million on 315 million gallons sold, with an average margin of around $1.30 per gallon. Management said core ingredients EBITDA finished at the high end of last quarter’s guidance at around $340 million. For the fourth quarter, DGD is expected to produce approximately 325 million gallons. Full-year 2026 combined adjusted EBITDA guidance was reaffirmed at $2.2 billion to $2.3 billion. Management also reiterated a target of net debt at or below $3 billion by year-end.
Randall Stuewe framed the quarter as evidence that Darling’s global ingredients business is resilient and that DGD remains a major cash engine even when quarter-to-quarter results are noisy. He highlighted strong protein demand, expected improvement in fat prices, and ongoing momentum in the Food segment’s collagen portfolio, including the new NxCogni launch. Tone-wise, he was confident and upbeat, stressing that the company has transformed into a more balanced, cash-generative business with options for 2027, including buybacks or a potential dividend once leverage falls further.
Robert Day focused on the financial mechanics behind the quarter’s results, saying core ingredients EBITDA was affected by about $30 million of timing and accounting items, including deferred profit on sales to DGD and a negative LCM adjustment. He said DGD generated $204 million of EBITDA on 315 million gallons, with some margin pressure from hedge losses, lower PTC capture, a Norco hydrogen outage, and lower RIN values, but noted those items should unwind in Q4. He also cited approximately $170 million in cash from DGD, over $300 million of cash from the core business and asset sales, a $420 million reduction in net debt, $76 million of share repurchases, leverage of about 1.7x, and 2026 tax guidance of about 25% effective tax rate and roughly $35 million of cash taxes for the rest of the year.
Analysts pressed management on DGD hedge risk, RIN policy, and whether the lower leverage level could support a dividend. Management said hedge gains and losses often reverse between quarters because Darling does not use mark-to-market accounting, and it was not concerned about the ability to manage risk. On policy, management said it expects the EPA to resolve the supplemental Set 2 process before moving to Set 3 and remains optimistic about 2028 and beyond. On capital allocation, management said it is debating the tradeoff between more buybacks and a dividend once net debt gets to around $2.5 billion.
The bull case from the call is that Darling is generating substantial cash from both the core business and DGD while steadily deleveraging. Management said underlying demand in protein and collagen remains strong, DGD replacement margins are attractive, and some Q3 headwinds were timing-related and should reverse in Q4. If those trends hold, the company appears positioned for more capital returns in 2027, including potentially larger buybacks or a dividend.
The main risks raised were tariff-related disruption in Food and Feed, quarter-to-quarter volatility at DGD, and uncertainty around policy timing for future RVO/Set 3 rules. Management also acknowledged the quarter was hurt by a third-party hydrogen outage, delayed SAF shipment, feedstock timing, and lower RIN values. While management was constructive, it also framed some of the Q3 gains as dependent on accounting reversals and favorable Q4 realization of hedging and deferred profit items.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 98.6%
- Shares Outstanding
- 154.94M
- Float Shares
- 152.78M
of shares held by institutions
647 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for DAR, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 16.04M | ▲ 447.38K |
| Vanguard Group Inc | 15.39M | ▲ 512.22K |
| Dimensional Fund Advisors LP | 8.45M | ▲ 231.58K |
| Vanguard Portfolio Management LLC | 8.27M | ▼ 80.80K |
| Vanguard Capital Management LLC | 7.08M | ▼ 108.86K |
| State Street Corp | 5.80M | ▲ 100.65K |
| Aqr Capital Management LLC | 4.41M | ▲ 446.85K |
| Geode Capital Management, LLC | 4.39M | ▲ 922.97K |
| Fmr LLC | 4.01M | ▲ 252.32K |
| Merewether Investment Management, LP | 3.73M | ▲ 728.54K |
| Invesco Ltd. | 3.71M | ▲ 1.31M |
| Earnest Partners LLC | 3.60M | ▼ 473.16K |
Held by 760 ETFs
Biggest fund positions in DAR by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 10, 26 | Adair Charles L | buy | 500 |
| Sep 2, 26 | STUEWE RANDALL C | sell | 5,000 |
| Aug 18, 26 | MANZI JOSEPH | sell | 1,000 |
| Aug 17, 26 | Dudley Sandra | other | 5,928 |
| Aug 17, 26 | Dudley Sandra | other | 3,330 |
| Aug 17, 26 | Dudley Sandra | sell | 2,598 |
| Aug 17, 26 | Dudley Sandra | sell | 3,876 |
| Aug 17, 26 | Dudley Sandra | other | 5,928 |
| Aug 14, 26 | McNutt Patrick | sell | 8,000 |
| Aug 12, 26 | STUEWE RANDALL C | sell | 5,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our DAR coverage
Recent articles, reports, and earnings notes.
No research on DAR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DAR report →162,225 Darling Ingredients Inc. $DAR Shares Purchased by Danske Bank A S
defenseworld.net · Nov 19
Darling Ingredients Inc. $DAR Stock Acquired by Ethic Inc.
defenseworld.net · Nov 12
Darling: 3 Key Takeaways for Long-Term Investors
fool.com · Nov 10
Darling Ingredients Inc. $DAR Shares Acquired by Chicago Partners Investment Group LLC
defenseworld.net · Nov 10
Darling Ingredients: Back On Track, With More To Prove
seekingalpha.com · Oct 31
What Darling Ingredients (DAR) Said on Its Q3 Earnings Call
marketbeat.com · Oct 30
Darling Ingredients Inc. (DAR) Q3 2026 Earnings Call Transcript
seekingalpha.com · Oct 29
DAR Q3 Earnings Surpass Estimates on Solid Feed Performance
zacks.com · Oct 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.